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What Should the Serum Creatinine Be After
Transplantation? An Approach to Integrate
Donor and Recipient Information to Assess
Posttransplant Kidney Function
Riyadh Al-Sehli,1,2 Scott Grebe,3 Zija Jacaj,1 Siwei Chen,1 Stone Li,1 Kelly Craig,1 Valerie Luyckx,1
and Thomas Mueller1,4
Background.Knowledge of an optimal expected serum creatinine (SCr) would be useful to detect early renal dysfunction after
transplantation. Current measurements of posttransplant function rely on the recipient's SCr and calculations of estimated glomer-
ular filtration rate (eGFR), based on recipient age, weight, and sex. Renal function after transplantation, however, also depends on
the donor supply of functioning nephrons and adaptation in GFR of a single kidney.Methods.Wedeveloped a formula to predict
the optimal expected SCr after transplantation derived from donor and recipient Cockroft-Gault GFRs and adjusted for the single
kidney adaptive response. We compared the expected SCr with the lowest observed SCr in a cohort of living (79) and deceased
(67) donor allograft recipients followed up over 5 years. Results. Expected SCr correlated with the observed SCr in both living
and deceased donor kidney recipients, correlation was stronger among living donor kidney recipients. Recipient-to-donor body
weight ratio was significantly associated with the difference between expected and observed SCr, suggesting that recipient body
weight is a major predictor of posttransplant renal function. The difference between expected and observed SCr was significantly
greater among deceased donor kidney recipients, suggesting poorer function in these patients, which was not detected by SCr or
estimated GFR alone. Conclusions. Calculation of expected renal function for a given donor-recipient combination adds rele-
vant information to assessment of allograft function. Future studies will permit determination of a threshold difference between ex-
pected and observed SCr that should trigger investigation and potential intervention to improve allograft function.
(Transplantation 2015;99: 1960–1967)
Antigen-independent factors, such as donor age, relativedonor and recipient sizes, donor cause of death, kidney
mass, donor glomerular filtration rate (GFR), recipient age,
and obesity are all associated with graft and patient survivals
after transplantation.1-10 These factors are likely to impact
renal function well before the endpoint of graft failure, but
detection of early allograft dysfunction is challenging, as the
true “baseline”, that is, optimal renal function for a given
donor-recipient combination, is not known. The lowest ob-
served creatinine (LoObsSCr) is often presumed to reflect
baseline renal function, but whether this is a true baseline
or reflects some ongoing renal dysfunction is not known.
Renal function is largely determined by the body's meta-
bolic demand.11-16 Thus, GFR is highly correlated with met-
abolic rate, and its key variables weight, age, and sex are
incorporated into formulae to estimate GFR (eGFR).17-19 In-
terestingly, these variables also correlate with nephron num-
ber and kidney size.11,13,14,20 Allograft function is generally
assessed by measuring the recipient's serum creatinine (SCr)
and using eGFR calculations, derived in subjects with native
kidneys, which incorporate the recipient's age, sex, and
weight.17,18,21,22 Posttransplant renal function is determined
by both the metabolic demand of the recipient and the neph-
ron supply of the donor, but donor factors are rarely taken
into account.2,6,12,23 In addition, GFR of a single kidneymust
respond to an increase in metabolic demand.16,24,25 This
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doubling, is predictable in healthy living donors (LDs).12,26
In the setting of transplantation, this AI-GFR is likely less pre-
dictable given additional nephron loss associated with
periprocedural and immunologic renal injury and nephro-
toxicmedication use. Given these peculiarities of transplanta-
tion, how best to determine whether a given recipient's renal
function is “good enough” or could/should be better is an im-
portant clinical challenge.
Two groups have proposed calculations to predict ex-
pected posttransplant kidney function by incorporating both
donor and recipient information.27,28 Sberro et al28 derived a
formula from recipient and donor Cockcroft and Gault
GFRs (CG-GFR) to calculate a “best possible” SCr in renal
allograft recipients. Oh et al27 derived an “ideal” creatinine
prediction formula by regression of observed SCr plotted
against the renal allograft weight-recipient body surface area
ratio. Both studies included only LD transplants, therefore
generalizability to deceased donor (DD) recipients, which
may be the greater group of concern, was not addressed. In
addition, although clinical variables included in the Sberro
formula are readily available, they did not consider the AI-
GFR of a single kidney in their formula and therefore may
be subject to a biased overestimation of expected GFR. The
Oh formula requires allograft weight which is not routinely
collected, limiting its utility. Nonetheless, these papers sug-
gest that establishment of an “ideal” SCr for an individual
donor-recipient combination would prompt therapeutic in-
tervention when observed function differed significantly
from expected function.27,28
In this proof-of-principle study, we have developed an
adapted formula to calculate the posttransplant expected
SCr (ExpSCr), by integrating parameters reflecting donor
supply, recipient demand, and the physiology of the single
kidney's adaptive increase. Given that there is no way to
know what a given donor-recipient SCr should be, we retro-
spectively evaluated the performance of the ExpSCr com-
pared to the observed creatinines (ObsScr) in recipients of
both LD and DD kidneys over 5 years.
METHODS
Patient Groups
Kidney function predonation and postdonation was ana-
lyzed in a group of 27 consecutive LDs. Expected and ob-
served SCr were analyzed in 146 consecutive recipients of
67 DD and 79 LD kidneys. All patients were transplanted
at the University of AlbertaHospital and followed for amean
(± SD) of 5.7 ± 1.4 years. Both transplant groups received
similar immunosuppressive therapy, based on steroids, my-
cophenolate mofetil, and tacrolimus. Delayed graft function
was defined as the requirement for dialysis within the first
week after transplantation. The study was approved by the
Human Research Ethics Board of the University of Alberta.
Donor and Recipient Data and Renal Function
Measurements
Baseline data were collected from donors and recipients at
the time of donation and transplantation. All body weights
used for the derived formulas are based on measured total
body weights, as baseline for the recipient, the weight on
the first outpatient visit was used. Kidney function was mea-
sured by SCr and by creatinine-based eGFR using the CG,
Modification of Diet in Renal Disease and CKD-EPI formu-
las.17-19,29 In recipients, posttransplant SCr was measured
daily until day 7 and then 6 monthly. There was no loss-to-
follow up. The LoObsSCr was obtained for each patient as
the lowest SCr measured within the first posttransplant year.
Development of the Equation to Calculate the
Expected Posttransplant SCr
Assessment of AI-GFR: the eGFR of 27 consecutive LDs
were analyzed before and after donation to quantify the
physiologic AI-GFR after removal of the contralateral kidney
for transplantation. The LD_GFR_pre and LD_GFR_post
were estimated from the LoObsSCr 1 year before and
1 year after donation using the CG formula. The linear rela-
tionship between LD_GFR_pre and LD_GFR_post was
tested by Pearson product-moment correlation. Linear re-
gression analysis was used to develop an equation to predict
LD_GFR_post based on LD_GFR_pre (a = regression coeffi-
cient and b = intercept):
LDGFR post¼ a∗DGFR preþ b 1
Integration of recipient demand and donor supply in a
creatinine-based formula: demand and supply are largely de-
fined by the key metabolic variables age, weight, and sex.We
used the CG formula which captures all 3 of these metabolic
markers.17 Incorporation of body weight was considered im-
portant because mismatch between donor and recipient
weight is a recognized predictor of long-term graft function6:
CGGFR ml= min½  ¼ age bwt gender
SCr
2
Clinically, SCr is most often used; therefore, the formula was
solved accordingly:
SCr μmol=L½  ¼ age bwt sex
GFR
3
Posttransplant kidney function is determined by the ratio of
recipient (R) demand to donor (D) supply. As used by Sberro
et al,28 the above formula is expressed as follows:
RExpSCr μmol=L½  ¼ R age Rbwt R sex
DGFR post
4
Considering the AI-GFR in a single kidney this formula can
be extended as follows incorporating formula (1) above:
RExpSCr μmol=l½  ¼ R age R bwt R gender
a∗DGFR preþ b
5
Here, the numerator reflects the recipient's demand and the
denominator reflects the donor supply and the donor's ex-
pected AI-GFR. This is better illustrated by transforming
the previous formula as:
RExpSCr μmol=L½  ¼ R age R bwt R gender
a∗ D  age  D  bwt  D genderD  SCr
 
þ b
6
Statistical Methods
Descriptive statistics were used for the analysis of study
groups, Kaplan-Meier survival estimates and log-rank tests
were used for comparison of survival curves. Mean values
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and frequencies were compared using the Wilcoxon test and
the Fisher exact test, respectively. To characterize and quan-
tify the relationship between parameters, Pearson correlation
coefficients were calculated, and linear regression analyses
were performed as a first step. In addition, Bland-Altman
plots were generated for better visualization of the data
and better assessment of concordance between ExpSCr
and LoObsSCr. Bias (mean difference between ExpSCr
and LoObsSCr) and limits of agreement (1.96  standard
deviation of the differences) with their 95% confidence in-
tervals were determined.30,31 Statistics were computed using
the SAS version 9.2 (SAS Institute Inc., Cary, NC).
RESULTS
Donor and recipient demographics were not different be-
tween LDs and DDs, as shown in Table 1. Predonation eGFR,
estimated by 3 formulae, was higher among DDs (P < 0.05).
Recipients in both groups were similar in age, weight, and
sex distribution. The DD recipients had longer ischemia
times, more HLA mismatches, and more delayed graft func-
tion. Mean follow-up was 5.7 ± 1.4 years. Six (7.6%) LD
and 13 (19.4%) DD recipients died. All DD recipient deaths
occurred with functioning grafts, 1 LD recipient experienced
graft failure due to nonadherence before death. One patient
returned to permanent dialysis in each group. Five-year graft
and patient survival rates were 94% and 94%, respectively,
for LD and 83% and 84 %, respectively, for DD recipients.
Adaptive Increase in Living Donor Kidney Function
Post-donation
The AI-GFR after donation was assessed by comparing
predonation (LD_GFR_pre) and postdonation (LD_GFR_
post) eGFRs in 27 LDs. The LD_GFR_pre and LD_GFR_
postcorrelated strongly (r = 0.89, P < 0.0001) with a mean
AI-GFR of 36 ± 18% (Figure 1A). Linear regression demon-
strated a high predictive accuracy (Figure 1B). The result-
ing equation to predict LD_GFR_post from LD_GFR_pre
is as follows:
LDGFR post¼ 0:6∗LDGFR preþ 8:7 7
The derived formula for ExpSCr (seeMethods) can therefore
be calculated as follows:
ExpSCr μmol=l½  ¼ R age R bwt R gender
0:6∗ D  age  D  bwt  D  genderD  SCr
 
þ 8:7
8
Formula parameters are: age = (140 − age) in years, bwt =
body weight in kilograms, and sex = 1.23 for men and 1.04
for women.
Performance of ExpSCr Equation in Living
and Deceased Donors
Agreement Between Observed and Expected SCr
The LoObsSCr and the ExpSCr showed a moderate but
significant correlation during the first posttransplant year
that was higher in LD compared to DD recipients (r = 0.64 vs
0.36, P < 0.001 vs 0.003, respectively). Data are displayed
using Bland-Altman plots (Figure 2). The limits of agreement
were smaller in LD (−47.3 μmol/L to 72.0 μmol/L) compared
to DD (−87.0 μmol/L to 70.6 μmol/L) recipients implying a
stronger concordance in LD recipients. Of interest, the out-
lier within the LD recipients with the highest disagreement
(ExpSCr of 83 μmol/L vs LoObsScr of 170 μmol/L) had is-
chemia of two thirds of the donor kidney due to vascular
problems identified in a posttransplant perfusion scan. The
TABLE 1.
Donor and recipient demographics
Living donors (n = 79) Deceased donors (n = 67) P
Age, y 44 ± 11 42 ± 17 0.55
Sex (M/F) 26/53 30/37 0.14
Weight, kg 75 ± 14 78 ± 20 0.35
SCr at donation, μmol/L 72 ± 13 68 ± 26 0.25
CG eGFR, mL/min 113 ± 30 138 ± 66 0.005
MDRD eGFR, mL/min 89 ± 28 114 ± 61 0.0015
CKD-EPI eGFR, mL/min 95 ± 20 105 ± 29 0.015
Living donor recipients
(n = 79)
Deceased donor recipients
(n = 67)
Age, y 48 ± 15 52 ± 13 0.071
Sex (M/F) 56/23 42/25 0.39
Weight, kg 82 ± 21 79 ± 17 0.38
Cold ischemia time, min 202 ± 96 980 ± 342 0.0001
Revascularization time, min 36 ± 7 40 ± 8 0.0041
DGF 1 13
HLA mismatches 3 ± 2 5 ± 1 0.0001
Duration of follow-up47 2202 ± 456 2056 ± 562 0.038
Lost follow-up 0 0
Death 6 13
Death with functioning graft 5 13
Failed grafts 1 1
MDRD, Modification of Diet in Renal Disease.
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bias for recipients of LD and DD allografts was 12.3 μmol/L
and −8.2 μmol/L, respectively, indicating that the calculated
ExpSCr slightly overestimates the actual measured LoObsSCr
in LD and vice versa in DD recipients.
Impact of Body Weight Ratio on Transplant Function
In Figure 3, the difference between ExpSCr and LoObsSCr
is plotted against recipient to donor (R/D) body weight ratio.
The scatter plots show that extremes of R/D body weight ra-
tio are associated with widening differences between ExpSCr
and LoObsSCr. Correlation between transplant function and
R/D body weight ratio was highly significant among LD re-
cipients (Figure 3A; r = 0.62, P = 0.000), but less strong
amongDD recipients (Figure 3B, r = 0.34, P = 0.006). Similar
analyses of R/D age or sex differences showed no correlation
(data not shown).
Five-Year Follow-up of Transplant Function
Table 2 gives for defined time points the ObsScr values, es-
timated CG-GFR levels and differences between ExpSCr and
ObsSCr for the LD versus DD recipients over 5 years. At
day 7, renal function was significantly better in LD compared
to DD kidneys. However, from month 3, SCr and CG-GFR
were not significantly different between LD and DD recipients
(eGFR by Modification of Diet in Renal Disease or CKD-EPI
formulae were also not different, data not shown). In contrast,
the difference between ExpSCr and ObsSCr was consistently
more negative (i.e., ObsScr was higher than expected) among
DD compared to LD recipients, suggesting persistently better
transplant function in LD compared to DD recipients. From
year 1 onward, the observed SCr was on average 40% higher
than expected in DD recipients compared to 10% higher in
recipient of LD kidneys (P < 0.05, Table 2).
DISCUSSION
Calculation of expected compared to observed SCr adds
information to assessment of renal transplant function. Com-
parison of ExpSCr versus ObsSCr over the first 5 years
showed that whereas standard measurements only detected
a difference in renal function early after transplantation, the
integrated formula identified a persistently larger gap be-
tween expected and achieved function in DD compared to
LD recipients. This observation is plausible and likely reflects
the multitude of factors negatively impacting DD kidneys
and the well-recognized better graft and patient survival in
LD recipients.32-34
Given that there is no method to determine the optimal
SCr for a given donor-recipient combination, the closest ap-
proximationmust logically incorporate data reflecting donor
nephron supply, recipient metabolic demand, and adjustment
for the expected physiological AI-GFR in a single kidney.11-15
The observations in our LD cohort corroborate the previ-
ously reported AI-GFR in the remaining donor kidney of
around 30% to 40%.24-26,28 The AI-GFR in the single
transplanted kidney has not been well described, therefore
we have modified Sberro's approach using the AI-GFR de-
rived from living donors.28 The AI-GFR in a renal allograft
is likely to be lower than that in a native single kidney and
may be lower in DD than LD kidneys. The impact of donor
age on the AI-GFR is difficult to predict; however, a recent
publication suggests that the compensatory response of the
remaining kidney in older donors is similar to standard do-
nors.35 Application of the LD AI-GFR here therefore repre-
sents a “best-case” scenario.
Posttransplant LoObsSCr correlated significantly with
ExpSCr in recipients of both LD and DD kidneys. In addi-
tion, the Bland-Altman plot showed a better agreement of
LoObsSCr and ExpSCr in recipients of LD compared to
DD kidneys. The weaker concordance in DD recipients does
demonstrate some internal consistency and likely reflects
greater heterogeneity among DDs. Importantly, terminal
SCr in DDs may not accurately reflect the donor's true base-
line as SCr may be impacted by volume resuscitation or acute
kidney injury predonation. As shown in Table 1, donor age,
sex, body weight, and SCr were not different between LD
and DD, although eGFRs were higher among DDs. How im-
precise individual predonation SCr levels would bias formula
accuracy, and in which direction, is difficult to predict. On
average, SCr was 6% lower among DDs, despite similar an-
thropomorphic data to LDs, suggesting this error may be
small. The real value of determining discrepancies between
expected and observed SCr after transplantation is to allow
for the identification of outliers, that is, posttransplant creat-
inine values that are significantly higher than expected should
FIGURE 1. Correlation between pre- and post-donation kidney function. A, The scatter plot shows the CG GFR level before and after dona-
tion for 27 living donors (r = 0.89, P < 0.0001). B, The fit plot gives the 95% confidence interval and prediction limits of the linear regression
model (F = 92.91, P < 0.0001).
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prompt thought and investigation. Clinically, erring on the
side of a lower ExpSCr would be preferable to overestima-
tion of ExpSCr, as in the latter case, a poorly functioning kid-
ney may not be identified early enough for successful
intervention. Conversely, however, potential anxiety relating
to investigation of overdiagnosed renal dysfunction is also
important. Given the lack of a gold standard, prospective
follow-up of the differences between ExpSCr and ObsSCr,
correlated with clinical outcomes over time, will best permit
determination of a clinically relevant threshold for this differ-
ence, not possible in this cohort given the small numbers and
short follow-up.
Body weight was a key factor impacting differences be-
tween expected and observed function. The R/D weight ra-
tio correlated significantly with the difference in ExpSCr
versus LoObsScr in both LD and DD recipients. A poten-
tial source of confounding is that recipient and donor
weights, respectively, appear on the numerator and de-
nominator of the ExpSCr formula (formula 6). Age and
sex ratios, appearing in similar positions in the formula,
were not correlated however, arguing for a true impact of
body weight on renal function. The lack of significant im-
pact of R/D ratios of sex or age compared to body weight
on the AI-GFR after transplantation is likely due to the
FIGURE 2. Bland-Altman plots comparing lowest observed and expected serum creatinine in the first year posttransplant in recipients of living
and deceased donor kidneys. The Bland-Altman plots show the difference between LoObsSCr and ExpSCr against their mean during the first
posttransplant year in 79 recipients of living donor (A) and 67 recipients of deceased donor kidneys (B). Bias—mean difference between
LoObsSCr and ExpSCr; limits of agreement—1.96  standard deviation of the differences with 95% confidence intervals.
1964 Transplantation ■ September 2015 ■ Volume 99 ■ Number 9 www.transplantjournal.com
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
overriding effect of weight as key determinant of metabolic
demand.16,36,37
In addition, if the correlation between R/D weight ratio
and the difference in ExpSCr versus LoObsScrwas an artifact
of calculation, the relationships should have been more simi-
lar between LDs and DDs. Although seemingly counterintu-
itive, given that a high R/D weight ratio is a risk factor for
poorer long-term graft function, our data suggest that in
the first 5 years, the AI-GFR is higher than anticipated for
small kidneys transplanted into large recipients and lower
than anticipated in large kidneys transplanted into small
donors.6,38 This observation is supported by others who
showed that the donor kidney adapts to the recipient's body
size and that a higher recipient body mass index is associated
with a higher GFR in the shorter term.15,16,36,39 Importantly,
higher GFRs in recipients with higher body mass index were
accompanied by higher filtration fractions, suggesting hy-
perfiltration.39 Healthy, single kidneysmaymaintain high fil-
tration without signs of significant damage over the long
term.12 In less healthy kidneys, however, a high metabolic
burden and consequent hyperfiltration may lead to progres-
sive deterioration in kidney function.2,6,40,41
Our choice of the CG eGFR formula may be considered a
weakness because the CKD-EPI formula performs better in
subjects with native kidneys.19 In addition, the CG formula
estimates creatinine clearance and not GFR, and may intro-
duce bias in overestimation of GFR at the lower levels of re-
nal function. In transplantation, however, the superiority of
one formula over another has not been proven, and with
GFRs > 45 mL/min per 1.73m2, which includes most stable
transplant patients, the CG-GFR performs well.42,43 We
therefore selected the CG-GFR, also to build on Sberro's pre-
vious work. Future studies should evaluate cystatin C-based
prediction formulae which may be superior.44 The consis-
tency of our findings of the AI-GFR in the LDs, based solely
on eGFRs, does support our use of eGFRs for comparisons
within and between donor groups. Utilization of the
LoObsSCr in year 1 as a reference against which to determine
accuracy of the ExpSCr is an inherent weakness in our and
other similar studies, given that a single low SCr may be an
outlier for a specific patient. At present, however, the
LoObsSCr is the closest reflection of a kidney's best possible
function. After year 1, however, we used ObSCr values at
each time point, avoiding this potential limitation. Another
important limitation is the use of surrogate markers for met-
abolic demand and nephron supply in the eGFR calculations.
Direct measurements of energy expenditure or nephron num-
ber are not routinely available; therefore; we used alternative
widely accepted markers.21,37,45 Changes in posttransplant
weight and percent lean body mass may impact recipient
metabolic demand and SCr values and thereforemay have af-
fected the accuracy of the eGFR and creatinine calculations.
FIGURE 3. Relationship between the difference in expected to ob-
served serum creatinine and the ratio of recipient to donor body
weight. The scatter plots indicate the correlation between the differ-
ence in ExpSCr to LoObsSCr in 79 recipients of living donor kidneys
(A), LD recipients and in 67 recipients of deceased donor kidneys (B),
DD recipients, respectively. The difference between ExpSCr and
LoObsSCr is given in percent on the x-axis, negative values denote
a transplant function lower, positive values higher than expected.
TABLE 2.
Posttransplant kidney function assessed by different approaches
Time point d 7 (79/67) mo 3 (78/65) y 1 (78/66) y 3 (75/59) y 4 (73/56) y 5 (68/52)
ObsSCr, μmol/L
LD 144 ± 79 132 ± 31 127 ± 37 120 ± 28 122 ± 34 125 ± 29
DD 235 ± 123 135 ± 70 120 ± 42 118 ± 36 126 ± 52 117 ± 51
P 0.0003 0.79 0.30 0.75 0.66 0.45
CG eGFR, mL/min
LD 68 ± 23 69 ± 22 72 ± 25 76 ± 27 73 ± 30 74 ± 16
DD 51 ± 25 66 ± 22 71 ± 23 72 ± 25 69 ± 27 75 ± 12
P <0.0001 0.45 0.7 0.38 0.42 0.87
ExpSCr-ObsSCr, %
LD −27 ± 63 −20 ± 42 −14 ± 41 −9 ± 38 −11 ± 41 −12 ± 33
DD −168 ± 228 −54 ± 78 −41 ± 67 −36 ± 57 −47 ± 86 −38 ± 56
P 0.0001 0.0014 0.004 0.0015 0.002 0.0021
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These factors likely contribute to the recognized under-
performance of GFR calculations in the transplant popula-
tion in general and are very difficult to control for in the
clinical setting.42 Subgroup analysis would have been ideal
to validate the clinical utility of our formula given all the
caveats; however, in this preliminary study, we elected not
to preselect cases, regardless of clinical events or extremes
of age or weight because of the small numbers.
The true utility of our ExpSCr versus ObsScr approach
cannot be determined from our cohort, as despite the gener-
ally lower than expected renal function in our DDs compared
to LDs, both groups showed stable transplant function and
excellent graft and patient survival rates over 5 years of
follow-up. The relatively short follow-up is therefore a limita-
tion, and it is possible, as with other cohorts, true differences
in outcomemay become apparent with time, whichwill assist
in better understanding of the impact of this approach.2,46
Assessment of organ function must reflect the uniqueness
of transplantation—the adaptation of an organ developed
to meet the donor's requirements subsequently introduced
into a setting of a different metabolic demand. Despite the
limitations discussed, we suggest that the proposed formula
is the most physiologically relevant current method to esti-
mate expected renal function after transplantation. Height-
ened awareness that an individual kidney may not be
functioning at its best possible “baseline” level is clinically
important and should prompt thought and investigation as
to why this discrepancy is present and potentially permit
early intervention to improve renal function and thereby op-
timize long-term transplant function.
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